Available 24/7

Seven Days A Week


Call Us For A Free Consultation




Fdazar > Proton Pump Inhibitor Injuries

Proton Pump Inhibitor Injuries

PPIs are commonly prescribed and available over the counter for the treatment of conditions such as acid reflux, heartburn, GERD, and peptic ulcer disease. These drugs work by reducing the production of and blocking acid buildup in the stomach.


Long term use of PPIs may cause problems with the body’s ability to absorb vital nutrients like calcium and magnesium. Patients who take these drugs for an extended period of time (typically more than one year) are at risk of suffering kidney damage and other serious side effects.

Long term PPI use has been linked to Acute Interstitial Nephritis (AIN) and Chronic Kidney Disease (CKD).


A study published in the February 2016 issue of the Journal of the American Medical Association (JAMA), has shown that use of PPI medications may increase the risk of chronic kidney disease (CKD), also known a chronic renal failure.

Another study published in the Journal of the American Society of Nephrology has linked the use of PPIs with a 96% increased risk of kidney failure and a 26% increased risk of chronic kidney disease.

List of PPIs

  • Nexium® (esomeprazole)
  • Prevacid®, Prevacid® 24-Hour (lansoprazole)
  • Prilosec®, Prilosec® OTC (omeprazole)
  • Aciphex® (rabeprazole)
  • Dexilant® (dexlansoprazole)
  • Protonix® (pantoprazole)
  • Vimovo® (naproxen / esomeprazole)
  • Zegerid® (omeprazole / sodium bicarbonate)

Our firm is currently evaluating claims for PPI lawsuits for anyone who has suffered kidney failure or has been diagnosed with chronic kidney disease or acute interstitial nephritis after daily use of the prescription strength or over the counter PPIs.

Please call if you have been diagnosed with kidney failure, chronic kidney disease (CKD) or acute interstitial nephritis (AIN) after long term, daily use of PPIs.

**** PRILOSEC® is a registered trademark of the AstraZeneca UK Limited and its Affiliates

NEXIUM® and the color purple as applied to the capsule are registered trademarks of the AstraZeneca UK Limited and its Affiliates